<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-03-29" modified="2020-10-07" version="166">
<accession>Q96CV9</accession>
<accession>B3KP00</accession>
<accession>D3DRS4</accession>
<accession>D3DRS8</accession>
<accession>Q5T672</accession>
<accession>Q5T673</accession>
<accession>Q5T674</accession>
<accession>Q5T675</accession>
<accession>Q7LDL9</accession>
<accession>Q8N562</accession>
<accession>Q9UET9</accession>
<accession>Q9UEV4</accession>
<accession>Q9Y218</accession>
<name>OPTN_HUMAN</name>
<protein>
<recommendedName>
<fullName>Optineurin</fullName>
</recommendedName>
<alternativeName>
<fullName>E3-14.7K-interacting protein</fullName>
</alternativeName>
<alternativeName>
<fullName>FIP-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Huntingtin yeast partner L</fullName>
</alternativeName>
<alternativeName>
<fullName>Huntingtin-interacting protein 7</fullName>
<shortName>HIP-7</shortName>
</alternativeName>
<alternativeName>
<fullName>Huntingtin-interacting protein L</fullName>
</alternativeName>
<alternativeName>
<fullName>NEMO-related protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Optic neuropathy-inducing protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Transcription factor IIIA-interacting protein</fullName>
<shortName>TFIIIA-IntP</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">OPTN</name>
<name type="synonym">FIP2</name>
<name type="synonym">GLC1E</name>
<name type="synonym">HIP7</name>
<name type="synonym">HYPL</name>
<name type="synonym">NRP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="1601" last="1610">
<title>Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains.</title>
<authorList>
<person name="Li Y."/>
<person name="Kang J."/>
<person name="Horwitz M.S."/>
</authorList>
<dbReference type="PubMed" id="9488477"/>
<dbReference type="DOI" id="10.1128/mcb.18.3.1601"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 3)</scope>
<scope>VARIANTS SER-201; HIS-213; ARG-216 AND PRO-357</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
<scope>INTERACTION WITH ADENOVIRUS E3</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2002" name="Science" volume="295" first="1077" last="1079">
<title>Adult-onset primary open-angle glaucoma caused by mutations in optineurin.</title>
<authorList>
<person name="Rezaie T."/>
<person name="Child A."/>
<person name="Hitchings R."/>
<person name="Brice G."/>
<person name="Miller L."/>
<person name="Coca-Prados M."/>
<person name="Heon E."/>
<person name="Krupin T."/>
<person name="Ritch R."/>
<person name="Kreutzer D."/>
<person name="Crick R.P."/>
<person name="Sarfarazi M."/>
</authorList>
<dbReference type="PubMed" id="11834836"/>
<dbReference type="DOI" id="10.1126/science.1066901"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS GLC1E LYS-50 AND GLN-545</scope>
<scope>VARIANTS LYS-98; SER-201; HIS-213; ARG-216 AND PRO-357</scope>
<source>
<tissue>Trabecular meshwork</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2000-06" db="EMBL/GenBank/DDBJ databases">
<title>Human FIP-2: genomic structure and mutational analysis in ARVD patients.</title>
<authorList>
<person name="Li D."/>
<person name="Roberts R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-201; HIS-213; ARG-216 AND PRO-357</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Cervix</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Hum. Mol. Genet." volume="7" first="1463" last="1474">
<title>Huntingtin interacts with a family of WW domain proteins.</title>
<authorList>
<person name="Faber P.W."/>
<person name="Barnes G.T."/>
<person name="Srinidhi J."/>
<person name="Chen J."/>
<person name="Gusella J.F."/>
<person name="MacDonald M.E."/>
</authorList>
<dbReference type="PubMed" id="9700202"/>
<dbReference type="DOI" id="10.1093/hmg/7.9.1463"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 412-555</scope>
<scope>INTERACTION WITH HD</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Curr. Biol." volume="10" first="1603" last="1606">
<title>FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis.</title>
<authorList>
<person name="Hattula K."/>
<person name="Peraenen J."/>
</authorList>
<dbReference type="PubMed" id="11137014"/>
<dbReference type="DOI" id="10.1016/s0960-9822(00)00864-2"/>
</citation>
<scope>INTERACTION WITH HD AND RAB8</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="22780" last="22789">
<title>Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-kappa B-independent pathway.</title>
<authorList>
<person name="Schwamborn K."/>
<person name="Weil R."/>
<person name="Courtois G."/>
<person name="Whiteside S.T."/>
<person name="Israeel A."/>
</authorList>
<dbReference type="PubMed" id="10807909"/>
<dbReference type="DOI" id="10.1074/jbc.m001500200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Nucleic Acids Res." volume="28" first="1986" last="1993">
<title>Identification of a transcription factor IIIA-interacting protein.</title>
<authorList>
<person name="Moreland R.J."/>
<person name="Dresser M.E."/>
<person name="Rodgers J.S."/>
<person name="Roe B.A."/>
<person name="Conaway J.W."/>
<person name="Conaway R.C."/>
<person name="Hanas J.S."/>
</authorList>
<dbReference type="PubMed" id="10756201"/>
<dbReference type="DOI" id="10.1093/nar/28.9.1986"/>
</citation>
<scope>INTERACTION WITH GTF3A</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="298" first="67" last="74">
<title>Expression of optineurin, a glaucoma-linked gene, is influenced by elevated intraocular pressure.</title>
<authorList>
<person name="Vittitow J."/>
<person name="Borras T."/>
</authorList>
<dbReference type="PubMed" id="12379221"/>
<dbReference type="DOI" id="10.1016/s0006-291x(02)02395-1"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Ophthalmic Res." volume="35" first="93" last="96">
<title>Optineurin gene expression level in human trabecular meshwork does not change in response to pressure elevation.</title>
<authorList>
<person name="Kamphuis W."/>
<person name="Schneemann A."/>
</authorList>
<dbReference type="PubMed" id="12646749"/>
<dbReference type="DOI" id="10.1159/000069133"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="169" first="285" last="295">
<title>Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis.</title>
<authorList>
<person name="Sahlender D.A."/>
<person name="Roberts R.C."/>
<person name="Arden S.D."/>
<person name="Spudich G."/>
<person name="Taylor M.J."/>
<person name="Luzio J.P."/>
<person name="Kendrick-Jones J."/>
<person name="Buss F."/>
</authorList>
<dbReference type="PubMed" id="15837803"/>
<dbReference type="DOI" id="10.1083/jcb.200501162"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH MYO6 AND RAB8</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="BMC Cell Biol." volume="11" first="4" last="4">
<title>Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant.</title>
<authorList>
<person name="Nagabhushana A."/>
<person name="Chalasani M.L."/>
<person name="Jain N."/>
<person name="Radha V."/>
<person name="Rangaraj N."/>
<person name="Balasubramanian D."/>
<person name="Swarup G."/>
</authorList>
<dbReference type="PubMed" id="20085643"/>
<dbReference type="DOI" id="10.1186/1471-2121-11-4"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TFRC AND RAB8A</scope>
<scope>MUTAGENESIS OF GLU-50 AND ASP-474</scope>
<scope>CHARACTERIZATION OF VARIANT GLC1E LYS-50</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="PLoS Pathog." volume="6" first="E1000778" last="E1000778">
<title>Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection.</title>
<authorList>
<person name="Mankouri J."/>
<person name="Fragkoudis R."/>
<person name="Richards K.H."/>
<person name="Wetherill L.F."/>
<person name="Harris M."/>
<person name="Kohl A."/>
<person name="Elliott R.M."/>
<person name="Macdonald A."/>
</authorList>
<dbReference type="PubMed" id="20174559"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1000778"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION</scope>
<scope>INTERACTION WITH TBK1 AND TRAF3</scope>
<scope>UBIQUITIN-BINDING MOTIF</scope>
<scope>MUTAGENESIS OF ASP-474</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2012" name="J. Cell Sci." volume="125" first="5026" last="5039">
<title>Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein TBC1D17.</title>
<authorList>
<person name="Vaibhava V."/>
<person name="Nagabhushana A."/>
<person name="Chalasani M.L."/>
<person name="Sudhakar C."/>
<person name="Kumari A."/>
<person name="Swarup G."/>
</authorList>
<dbReference type="PubMed" id="22854040"/>
<dbReference type="DOI" id="10.1242/jcs.102327"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TBC1D17</scope>
<scope>INTERACTION WITH RAB8A</scope>
<scope>CHARACTERIZATION OF VARIANT GLC1E LYS-50</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="J. Cell Sci." volume="126" first="3237" last="3247">
<title>The LIR motif - crucial for selective autophagy.</title>
<authorList>
<person name="Birgisdottir A.B."/>
<person name="Lamark T."/>
<person name="Johansen T."/>
</authorList>
<dbReference type="PubMed" id="23908376"/>
<dbReference type="DOI" id="10.1242/jcs.126128"/>
</citation>
<scope>LIR MOTIF</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177 AND SER-526</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="Hum. Mol. Genet." volume="23" first="4142" last="4160">
<title>The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease.</title>
<authorList>
<person name="Butland S.L."/>
<person name="Sanders S.S."/>
<person name="Schmidt M.E."/>
<person name="Riechers S.P."/>
<person name="Lin D.T."/>
<person name="Martin D.D."/>
<person name="Vaid K."/>
<person name="Graham R.K."/>
<person name="Singaraja R.R."/>
<person name="Wanker E.E."/>
<person name="Conibear E."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="24705354"/>
<dbReference type="DOI" id="10.1093/hmg/ddu137"/>
</citation>
<scope>INTERACTION WITH ZDHHC17</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-198 AND SER-342</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2016" name="BMC Biol." volume="14" first="69" last="69">
<title>The Golgi apparatus acts as a platform for TBK1 activation after viral RNA sensing.</title>
<authorList>
<person name="Pourcelot M."/>
<person name="Zemirli N."/>
<person name="Silva Da Costa L."/>
<person name="Loyant R."/>
<person name="Garcin D."/>
<person name="Vitour D."/>
<person name="Munitic I."/>
<person name="Vazquez A."/>
<person name="Arnoult D."/>
</authorList>
<dbReference type="PubMed" id="27538435"/>
<dbReference type="DOI" id="10.1186/s12915-016-0292-z"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TBK1 AND BLUETONGUE VIRUS PROTEIN NS3</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Biochem. J." volume="454" first="459" last="466">
<title>Structural basis for phosphorylation-triggered autophagic clearance of Salmonella.</title>
<authorList>
<person name="Rogov V.V."/>
<person name="Suzuki H."/>
<person name="Fiskin E."/>
<person name="Wild P."/>
<person name="Kniss A."/>
<person name="Rozenknop A."/>
<person name="Kato R."/>
<person name="Kawasaki M."/>
<person name="McEwan D.G."/>
<person name="Lohr F."/>
<person name="Guntert P."/>
<person name="Dikic I."/>
<person name="Wakatsuki S."/>
<person name="Dotsch V."/>
</authorList>
<dbReference type="PubMed" id="23805866"/>
<dbReference type="DOI" id="10.1042/bj20121907"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 170-181</scope>
<scope>STRUCTURE BY NMR OF 169-185</scope>
<scope>INTERACTION WITH MAP1LC3B</scope>
<scope>MUTAGENESIS OF MUTAGENESIS OF PHE-178</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2003" name="J. Med. Genet." volume="40" first="842" last="844">
<title>The M98K variant of the OPTINEURIN (OPTN) gene modifies initial intraocular pressure in patients with primary open angle glaucoma.</title>
<authorList>
<person name="Melki R."/>
<person name="Belmouden A."/>
<person name="Akhayat O."/>
<person name="Brezin A."/>
<person name="Garchon H.-J."/>
</authorList>
<dbReference type="PubMed" id="14627677"/>
<dbReference type="DOI" id="10.1136/jmg.40.11.842"/>
</citation>
<scope>VARIANT LYS-98</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2003" name="Invest. Ophthalmol. Vis. Sci." volume="44" first="3880" last="3884">
<title>Different optineurin mutation pattern in primary open-angle glaucoma.</title>
<authorList>
<person name="Leung Y.F."/>
<person name="Fan B.J."/>
<person name="Lam D.S.C."/>
<person name="Lee W.S."/>
<person name="Tam P.O.S."/>
<person name="Chua J.K.H."/>
<person name="Tham C.C.Y."/>
<person name="Lai J.S.M."/>
<person name="Fan D.S.P."/>
<person name="Pang C.P."/>
</authorList>
<dbReference type="PubMed" id="12939304"/>
<dbReference type="DOI" id="10.1167/iovs.02-0693"/>
</citation>
<scope>VARIANTS GLC1E ASP-103 AND ARG-486</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2003" name="Am. J. Ophthalmol." volume="136" first="904" last="910">
<title>Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma.</title>
<authorList>
<person name="Alward W.L.M."/>
<person name="Kwon Y.H."/>
<person name="Kawase K."/>
<person name="Craig J.E."/>
<person name="Hayreh S.S."/>
<person name="Johnson A.T."/>
<person name="Khanna C.L."/>
<person name="Yamamoto T."/>
<person name="Mackey D.A."/>
<person name="Roos B.R."/>
<person name="Affatigato L.M."/>
<person name="Sheffield V.C."/>
<person name="Stone E.M."/>
</authorList>
<dbReference type="PubMed" id="14597044"/>
<dbReference type="DOI" id="10.1016/s0002-9394(03)00577-4"/>
</citation>
<scope>VARIANT GLC1E GLN-545</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="Autophagy" volume="9" first="510" last="527">
<title>M98K-OPTN induces transferrin receptor degradation and RAB12-mediated autophagic death in retinal ganglion cells.</title>
<authorList>
<person name="Sirohi K."/>
<person name="Chalasani M.L."/>
<person name="Sudhakar C."/>
<person name="Kumari A."/>
<person name="Radha V."/>
<person name="Swarup G."/>
</authorList>
<dbReference type="PubMed" id="23357852"/>
<dbReference type="DOI" id="10.4161/auto.23458"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT LYS-98</scope>
<scope>INTERACTION WITH RAB12</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E95758" last="E95758">
<title>E50K-OPTN-induced retinal cell death involves the Rab GTPase-activating protein, TBC1D17 mediated block in autophagy.</title>
<authorList>
<person name="Chalasani M.L."/>
<person name="Kumari A."/>
<person name="Radha V."/>
<person name="Swarup G."/>
</authorList>
<dbReference type="PubMed" id="24752605"/>
<dbReference type="DOI" id="10.1371/journal.pone.0095758"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT GLC1E LYS-50</scope>
<scope>MUTAGENESIS OF GLU-50 AND ASP-474</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="Hum. Mol. Genet." volume="22" first="3559" last="3567">
<title>Enhanced optineurin E50K-TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma.</title>
<authorList>
<person name="Minegishi Y."/>
<person name="Iejima D."/>
<person name="Kobayashi H."/>
<person name="Chi Z.L."/>
<person name="Kawase K."/>
<person name="Yamamoto T."/>
<person name="Seki T."/>
<person name="Yuasa S."/>
<person name="Fukuda K."/>
<person name="Iwata T."/>
</authorList>
<dbReference type="PubMed" id="23669351"/>
<dbReference type="DOI" id="10.1093/hmg/ddt210"/>
</citation>
<scope>SELF-ASSOCIATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TBK1</scope>
<scope>CHARACTERIZATION OF VARIANT GLC1E LYS-50</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2004" name="Clin. Exp. Ophthalmol." volume="32" first="518" last="522">
<title>Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the blue mountains eye study.</title>
<authorList>
<person name="Baird P.N."/>
<person name="Richardson A.J."/>
<person name="Craig J.E."/>
<person name="Mackey D.A."/>
<person name="Rochtchina E."/>
<person name="Mitchell P."/>
</authorList>
<dbReference type="PubMed" id="15498064"/>
<dbReference type="DOI" id="10.1111/j.1442-9071.2004.00886.x"/>
</citation>
<scope>VARIANT LYS-98</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="Invest. Ophthalmol. Vis. Sci." volume="45" first="3122" last="3130">
<title>Defining the pathogenicity of optineurin in juvenile open-angle glaucoma.</title>
<authorList>
<person name="Willoughby C.E."/>
<person name="Chan L.L.Y."/>
<person name="Herd S."/>
<person name="Billingsley G."/>
<person name="Noordeh N."/>
<person name="Levin A.V."/>
<person name="Buys Y."/>
<person name="Trope G."/>
<person name="Sarfarazi M."/>
<person name="Heon E."/>
</authorList>
<dbReference type="PubMed" id="15326130"/>
<dbReference type="DOI" id="10.1167/iovs.04-0107"/>
</citation>
<scope>VARIANT GLC1E ARG-486</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2004" name="Invest. Ophthalmol. Vis. Sci." volume="45" first="4359" last="4367">
<title>Variants in optineurin gene and their association with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma.</title>
<authorList>
<person name="Funayama T."/>
<person name="Ishikawa K."/>
<person name="Ohtake Y."/>
<person name="Tanino T."/>
<person name="Kurosaka D."/>
<person name="Kimura I."/>
<person name="Suzuki K."/>
<person name="Ideta H."/>
<person name="Nakamoto K."/>
<person name="Yasuda N."/>
<person name="Fujimaki T."/>
<person name="Murakami A."/>
<person name="Asaoka R."/>
<person name="Hotta Y."/>
<person name="Tanihara H."/>
<person name="Kanamoto T."/>
<person name="Mishima H."/>
<person name="Fukuchi T."/>
<person name="Abe H."/>
<person name="Iwata T."/>
<person name="Shimada N."/>
<person name="Kudoh J."/>
<person name="Shimizu N."/>
<person name="Mashima Y."/>
</authorList>
<dbReference type="PubMed" id="15557444"/>
<dbReference type="DOI" id="10.1167/iovs.03-1403"/>
</citation>
<scope>VARIANTS GLC1E ASP-26 AND GLN-545</scope>
<scope>VARIANT LYS-98</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2004" name="J. Glaucoma" volume="13" first="299" last="303">
<title>Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population.</title>
<authorList>
<person name="Fuse N."/>
<person name="Takahashi K."/>
<person name="Akiyama H."/>
<person name="Nakazawa T."/>
<person name="Seimiya M."/>
<person name="Kuwahara S."/>
<person name="Tamai M."/>
</authorList>
<dbReference type="PubMed" id="15226658"/>
<dbReference type="DOI" id="10.1097/00061198-200408000-00007"/>
</citation>
<scope>VARIANT GLC1E ASP-26</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2004" name="Ophthalmic Genet." volume="25" first="91" last="99">
<title>Clinical relevance of optineurin sequence alterations in Japanese glaucoma patients.</title>
<authorList>
<person name="Umeda T."/>
<person name="Matsuo T."/>
<person name="Nagayama M."/>
<person name="Tamura N."/>
<person name="Tanabe Y."/>
<person name="Ohtsuki H."/>
</authorList>
<dbReference type="PubMed" id="15370540"/>
<dbReference type="DOI" id="10.1080/13816810490514298"/>
</citation>
<scope>VARIANT NPG ASP-26</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="Invest. Ophthalmol. Vis. Sci." volume="48" first="1607" last="1614">
<title>A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants.</title>
<authorList>
<person name="Chalasani M.L."/>
<person name="Radha V."/>
<person name="Gupta V."/>
<person name="Agarwal N."/>
<person name="Balasubramanian D."/>
<person name="Swarup G."/>
</authorList>
<dbReference type="PubMed" id="17389490"/>
<dbReference type="DOI" id="10.1167/iovs.06-0834"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT GLC1E LYS-50</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="Nature" volume="465" first="223" last="226">
<title>Mutations of optineurin in amyotrophic lateral sclerosis.</title>
<authorList>
<person name="Maruyama H."/>
<person name="Morino H."/>
<person name="Ito H."/>
<person name="Izumi Y."/>
<person name="Kato H."/>
<person name="Watanabe Y."/>
<person name="Kinoshita Y."/>
<person name="Kamada M."/>
<person name="Nodera H."/>
<person name="Suzuki H."/>
<person name="Komure O."/>
<person name="Matsuura S."/>
<person name="Kobatake K."/>
<person name="Morimoto N."/>
<person name="Abe K."/>
<person name="Suzuki N."/>
<person name="Aoki M."/>
<person name="Kawata A."/>
<person name="Hirai T."/>
<person name="Kato T."/>
<person name="Ogasawara K."/>
<person name="Hirano A."/>
<person name="Takumi T."/>
<person name="Kusaka H."/>
<person name="Hagiwara K."/>
<person name="Kaji R."/>
<person name="Kawakami H."/>
</authorList>
<dbReference type="PubMed" id="20428114"/>
<dbReference type="DOI" id="10.1038/nature08971"/>
</citation>
<scope>VARIANT ALS12 GLY-478</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="Science" volume="333" first="228" last="233">
<title>Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth.</title>
<authorList>
<person name="Wild P."/>
<person name="Farhan H."/>
<person name="McEwan D.G."/>
<person name="Wagner S."/>
<person name="Rogov V.V."/>
<person name="Brady N.R."/>
<person name="Richter B."/>
<person name="Korac J."/>
<person name="Waidmann O."/>
<person name="Choudhary C."/>
<person name="Dotsch V."/>
<person name="Bumann D."/>
<person name="Dikic I."/>
</authorList>
<dbReference type="PubMed" id="21617041"/>
<dbReference type="DOI" id="10.1126/science.1205405"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH MAP1LC3A; MAP1LC3B; GABARAP; GABARAPL1 AND GABARAPL2</scope>
<scope>PHOSPHORYLATION AT SER-177 BY TBK1</scope>
<scope>UBIQUITIN-BINDING</scope>
<scope>MUTAGENESIS OF PHE-178 AND 474-ASP-PHE-475</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2017" name="Amyotroph. Lateral Scler. Frontotemporal Degener." volume="18" first="126" last="133">
<title>A novel amyotrophic lateral sclerosis mutation in OPTN induces ER stress and Golgi fragmentation in vitro.</title>
<authorList>
<person name="Fifita J.A."/>
<person name="Williams K.L."/>
<person name="Sundaramoorthy V."/>
<person name="Mccann E.P."/>
<person name="Nicholson G.A."/>
<person name="Atkin J.D."/>
<person name="Blair I.P."/>
</authorList>
<dbReference type="PubMed" id="27534431"/>
<dbReference type="DOI" id="10.1080/21678421.2016.1218517"/>
</citation>
<scope>VARIANT ALS12 PHE-295</scope>
<scope>CHARACTERIZATION OF VARIANT ALS12 PHE-295</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="13 24 26 27 29 30 37 38">Plays an important role in the maintenance of the Golgi complex, in membrane trafficking, in exocytosis, through its interaction with myosin VI and Rab8 (PubMed:27534431). Links myosin VI to the Golgi complex and plays an important role in Golgi ribbon formation (PubMed:27534431). Plays a role in the activation of innate immune response during viral infection. Mechanistically, recruits TBK1 at the Golgi apparatus, promoting its trans-phosphorylation after RLR or TLR3 stimulation (PubMed:27538435). In turn, activated TBK1 phosphorylates its downstream partner IRF3 to produce IFN-beta. Plays a neuroprotective role in the eye and optic nerve. May act by regulating membrane trafficking and cellular morphogenesis via a complex that contains Rab8 and hungtingtin (HD). Mediates the interaction of Rab8 with the probable GTPase-activating protein TBC1D17 during Rab8-mediated endocytic trafficking, such as of transferrin receptor (TFRC/TfR); regulates Rab8 recruitment to tubules emanating from the endocytic recycling compartment. Autophagy receptor that interacts directly with both the cargo to become degraded and an autophagy modifier of the MAP1 LC3 family; targets ubiquitin-coated bacteria (xenophagy), such as cytoplasmic Salmonella enterica, and appears to function in the same pathway as SQSTM1 and CALCOCO2/NDP52.</text>
</comment>
<comment type="function">
<text evidence="38 39">(Microbial infection) May constitute a cellular target for adenovirus E3 14.7 and Bluetongue virus protein NS3 to inhibit innate immune response.</text>
</comment>
<comment type="subunit">
<text evidence="10 12 24 26 27 29 30 31 32 33 35 38 40">Self-associates (PubMed:23669351). Interacts with HD, Rab8 (RAB8A and/or RAB8B) (active GTP-bound form), GTF3A, TRAF3, TBK1, MYO6 and TFRC. Binds to linear ubiquitin chains. Interacts with LC3 family members MAP1LC3A, MAP1LC3B, GABARAP, GABARAPL1 and GABARAPL2; OPTN phosphorylation increases the association (at least with MAP1LC3B). Interacts with RAB12; the interaction may be indirect. Interacts with TBK1; this interaction leads to the Golgi localization of TBK1 and its subsequent activation. Interacts with palmitoyltransferase ZDHHC17/HIP14; the interaction does not lead to palmitoylation of OPTN (PubMed:24705354).</text>
</comment>
<comment type="subunit">
<text evidence="38 39">(Microbial infection) Interacts with E3 14.7 kDa protein of group C human adenovirus (PubMed:9488477). Interacts with Bluetongue virus protein NS3 (PubMed:27538435).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-12412735">
<id>Q12904-2</id>
<label>AIMP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-1056102">
<id>Q13023</id>
<label>AKAP6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-2875665">
<id>Q96B67</id>
<label>ARRDC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-10961312">
<id>Q8IYE1</id>
<label>CCDC13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-396137">
<id>Q9UJX2</id>
<label>CDC23</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-724310">
<id>Q15038</id>
<label>DAZAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-310758">
<id>Q03001</id>
<label>DST</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-2799016">
<id>O75923</id>
<label>DYSF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-308277">
<id>Q8IYU2</id>
<label>HACE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-7116203">
<id>O75031</id>
<label>HSF2BP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-466029">
<id>P42858</id>
<label>HTT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-2340947">
<id>Q8N448</id>
<label>LNX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-711788">
<id>Q00013</id>
<label>MPP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-9819090">
<id>P54845-1</id>
<label>NRL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
<label>OPTN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-79165">
<id>Q9NRD5</id>
<label>PICK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-12029004">
<id>P78424</id>
<label>POU6F2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-726075">
<id>P61026</id>
<label>RAB10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-722293">
<id>P61006</id>
<label>RAB8A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-310707">
<id>Q9NTZ6</id>
<label>RBM12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-723313">
<id>Q9NWF9</id>
<label>RNF216</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-727004">
<id>O00560</id>
<label>SDCBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-1043216">
<id>Q14BN4</id>
<label>SLMAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-949294">
<id>Q9UNH7</id>
<label>SNX6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-307104">
<id>Q13501</id>
<label>SQSTM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-1048247">
<id>Q8TC07</id>
<label>TBC1D15</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-714625">
<id>Q9HA65</id>
<label>TBC1D17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
<label>TBK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-357849">
<id>Q15025</id>
<label>TNIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-681210">
<id>Q8WZ42</id>
<label>TTN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-743272">
<id>O75604</id>
<label>USP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-981819">
<id>P04275</id>
<label>VWF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-712969">
<id>Q9Y3C0</id>
<label>WASHC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>17</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-1105334">
<id>P17021</id>
<label>ZNF17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-7233259">
<id>Q86UD4</id>
<label>ZNF329</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-8643207">
<id>Q8TD17</id>
<label>ZNF398</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-743265">
<id>Q9BUY5</id>
<label>ZNF426</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-745276">
<id>Q9BS34</id>
<label>ZNF670</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-15804516">
<id>Q29122</id>
<label>MYO6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748974">
<id>Q96CV9</id>
</interactant>
<interactant intactId="EBI-6858501">
<id>PRO_0000045599</id>
<dbReference type="UniProtKB" id="Q99IB8"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9091423">
<id>Q96CV9-2</id>
</interactant>
<interactant intactId="EBI-725647">
<id>Q99732</id>
<label>LITAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9091423">
<id>Q96CV9-2</id>
</interactant>
<interactant intactId="EBI-524753">
<id>Q8IUH5</id>
<label>ZDHHC17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="37 38">Golgi apparatus</location>
</subcellularLocation>
<subcellularLocation>
<location>Golgi apparatus</location>
<location>trans-Golgi network</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
<location>Autophagosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
</subcellularLocation>
<subcellularLocation>
<location>Recycling endosome</location>
</subcellularLocation>
<text evidence="37">Found in the perinuclear region and associates with the Golgi apparatus (PubMed:27534431). Colocalizes with MYO6 and RAB8 at the Golgi complex and in vesicular structures close to the plasma membrane. Localizes to LC3-positive cytoplasmic vesicles upon induction of autophagy.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q96CV9-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q96CV9-2</id>
<name>2</name>
<sequence type="described" ref="VSP_013262"/>
</isoform>
<isoform>
<id>Q96CV9-3</id>
<name>3</name>
<sequence type="described" ref="VSP_013261"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13 39">Present in aqueous humor of the eye (at protein level). Highly expressed in trabecular meshwork. Expressed nonpigmented ciliary epithelium, retina, brain, adrenal cortex, fetus, lymphocyte, fibroblast, skeletal muscle, heart, liver, brain and placenta.</text>
</comment>
<comment type="induction">
<text evidence="11 14 15 27 39">Upon TNF and interferon treatments. Up-regulated in direct response to viral infection.</text>
</comment>
<comment type="domain">
<text>Ubiquitin-binding motif (UBAN) is essential for its inhibitory function, subcellular localization and interaction with TBK1.</text>
</comment>
<comment type="domain">
<text evidence="34">The LIR (LC3-interacting region) motif mediates the interaction with ATG8 family proteins.</text>
</comment>
<comment type="PTM">
<text evidence="11 29">Phosphorylated by TBK1, leading to restrict bacterial proliferation in case of infection. Phosphorylation is induced by phorbol esters and decreases its half-time.</text>
</comment>
<comment type="disease" evidence="13 16 17 19 20 23 25 26 30 32 36">
<disease id="DI-00938">
<name>Glaucoma 1, open angle, E</name>
<acronym>GLC1E</acronym>
<description>A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place.</description>
<dbReference type="MIM" id="137760"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="21">
<disease id="DI-00879">
<name>Glaucoma, normal pressure</name>
<acronym>NPG</acronym>
<description>A primary glaucoma characterized by intraocular pression consistently within the statistically normal population range.</description>
<dbReference type="MIM" id="606657"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="28 37">
<disease id="DI-02705">
<name>Amyotrophic lateral sclerosis 12</name>
<acronym>ALS12</acronym>
<description>A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases.</description>
<dbReference type="MIM" id="613435"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="caution">
<text evidence="45 46">According to some authors (PubMed:12379221) its expression is regulated by intraocular pressure, suggesting a protective role in case of high pressure, while according to other authors (PubMed:12646749), it is not up-regulated in response to pressure elevation.</text>
</comment>
<comment type="caution">
<text evidence="47 48">Interaction of variant GLC1E LYS-50 with Rab8 is reported conflictingly. Coimmunoprecipitation experiments with overexpressed proteins suggested an increased interaction (PubMed:20085643) while yeast-two-hybrid (PubMed:22854040) and protein complentation assays with an equivalent mouse Optn construct (AC Q8K3K8) failed to show an interaction.</text>
</comment>
<dbReference type="EMBL" id="AF061034">
<property type="protein sequence ID" value="AAC16046.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF061034">
<property type="protein sequence ID" value="AAC16047.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF420371">
<property type="protein sequence ID" value="AAL76327.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF420372">
<property type="protein sequence ID" value="AAL76328.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF420373">
<property type="protein sequence ID" value="AAL76329.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283527">
<property type="protein sequence ID" value="AAG00497.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283520">
<property type="protein sequence ID" value="AAG00497.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283521">
<property type="protein sequence ID" value="AAG00497.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283522">
<property type="protein sequence ID" value="AAG00497.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283523">
<property type="protein sequence ID" value="AAG00497.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283524">
<property type="protein sequence ID" value="AAG00497.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283525">
<property type="protein sequence ID" value="AAG00497.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF283526">
<property type="protein sequence ID" value="AAG00497.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK055403">
<property type="protein sequence ID" value="BAG51512.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL355355">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86301.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86302.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86303.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86304.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86306.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86308.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86309.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC013876">
<property type="protein sequence ID" value="AAH13876.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032762">
<property type="protein sequence ID" value="AAH32762.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF049614">
<property type="protein sequence ID" value="AAC26850.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7094.1">
<molecule id="Q96CV9-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001008212.1">
<molecule id="Q96CV9-1"/>
<property type="nucleotide sequence ID" value="NM_001008211.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001008213.1">
<molecule id="Q96CV9-1"/>
<property type="nucleotide sequence ID" value="NM_001008212.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001008214.1">
<molecule id="Q96CV9-1"/>
<property type="nucleotide sequence ID" value="NM_001008213.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_068815.2">
<molecule id="Q96CV9-1"/>
<property type="nucleotide sequence ID" value="NM_021980.4"/>
</dbReference>
<dbReference type="PDB" id="2LO4">
<property type="method" value="NMR"/>
<property type="chains" value="A=550-577"/>
</dbReference>
<dbReference type="PDB" id="2LUE">
<property type="method" value="NMR"/>
<property type="chains" value="B=169-185"/>
</dbReference>
<dbReference type="PDB" id="3VTV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=170-181"/>
</dbReference>
<dbReference type="PDB" id="3VTW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="A/B/C=170-181"/>
</dbReference>
<dbReference type="PDB" id="5AAZ">
<property type="method" value="NMR"/>
<property type="chains" value="A=548-577"/>
</dbReference>
<dbReference type="PDB" id="5B83">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.69"/>
<property type="chains" value="B/C/E/F=416-510"/>
</dbReference>
<dbReference type="PDB" id="5EOA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=26-103"/>
</dbReference>
<dbReference type="PDB" id="5EOF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B=26-103"/>
</dbReference>
<dbReference type="PDBsum" id="2LO4"/>
<dbReference type="PDBsum" id="2LUE"/>
<dbReference type="PDBsum" id="3VTV"/>
<dbReference type="PDBsum" id="3VTW"/>
<dbReference type="PDBsum" id="5AAZ"/>
<dbReference type="PDBsum" id="5B83"/>
<dbReference type="PDBsum" id="5EOA"/>
<dbReference type="PDBsum" id="5EOF"/>
<dbReference type="SMR" id="Q96CV9"/>
<dbReference type="BioGRID" id="115436">
<property type="interactions" value="112"/>
</dbReference>
<dbReference type="CORUM" id="Q96CV9"/>
<dbReference type="DIP" id="DIP-42001N"/>
<dbReference type="IntAct" id="Q96CV9">
<property type="interactions" value="95"/>
</dbReference>
<dbReference type="MINT" id="Q96CV9"/>
<dbReference type="STRING" id="9606.ENSP00000368022"/>
<dbReference type="iPTMnet" id="Q96CV9"/>
<dbReference type="MetOSite" id="Q96CV9"/>
<dbReference type="PhosphoSitePlus" id="Q96CV9"/>
<dbReference type="BioMuta" id="OPTN"/>
<dbReference type="DMDM" id="317373403"/>
<dbReference type="EPD" id="Q96CV9"/>
<dbReference type="jPOST" id="Q96CV9"/>
<dbReference type="MassIVE" id="Q96CV9"/>
<dbReference type="PaxDb" id="Q96CV9"/>
<dbReference type="PeptideAtlas" id="Q96CV9"/>
<dbReference type="PRIDE" id="Q96CV9"/>
<dbReference type="ProteomicsDB" id="76226">
<molecule id="Q96CV9-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="76227">
<molecule id="Q96CV9-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="76228">
<molecule id="Q96CV9-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="1010">
<property type="antibodies" value="354 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="10133"/>
<dbReference type="Ensembl" id="ENST00000263036">
<molecule id="Q96CV9-1"/>
<property type="protein sequence ID" value="ENSP00000263036"/>
<property type="gene ID" value="ENSG00000123240"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000378747">
<molecule id="Q96CV9-1"/>
<property type="protein sequence ID" value="ENSP00000368021"/>
<property type="gene ID" value="ENSG00000123240"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000378748">
<molecule id="Q96CV9-1"/>
<property type="protein sequence ID" value="ENSP00000368022"/>
<property type="gene ID" value="ENSG00000123240"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000378752">
<molecule id="Q96CV9-2"/>
<property type="protein sequence ID" value="ENSP00000368027"/>
<property type="gene ID" value="ENSG00000123240"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000378757">
<molecule id="Q96CV9-1"/>
<property type="protein sequence ID" value="ENSP00000368032"/>
<property type="gene ID" value="ENSG00000123240"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000378764">
<molecule id="Q96CV9-2"/>
<property type="protein sequence ID" value="ENSP00000368040"/>
<property type="gene ID" value="ENSG00000123240"/>
</dbReference>
<dbReference type="GeneID" id="10133"/>
<dbReference type="KEGG" id="hsa:10133"/>
<dbReference type="UCSC" id="uc001ilv.2">
<molecule id="Q96CV9-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10133"/>
<dbReference type="DisGeNET" id="10133"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000123240.16"/>
<dbReference type="GeneCards" id="OPTN"/>
<dbReference type="GeneReviews" id="OPTN"/>
<dbReference type="HGNC" id="HGNC:17142">
<property type="gene designation" value="OPTN"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000123240">
<property type="expression patterns" value="Tissue enriched (skeletal)"/>
</dbReference>
<dbReference type="MalaCards" id="OPTN"/>
<dbReference type="MIM" id="137760">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="602432">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="606657">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613435">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96CV9"/>
<dbReference type="OpenTargets" id="ENSG00000123240"/>
<dbReference type="Orphanet" id="803">
<property type="disease" value="Amyotrophic lateral sclerosis"/>
</dbReference>
<dbReference type="Orphanet" id="353225">
<property type="disease" value="NON RARE IN EUROPE: Primary adult open-angle glaucoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31948"/>
<dbReference type="eggNOG" id="ENOG502QTG2">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063808"/>
<dbReference type="HOGENOM" id="CLU_034097_1_0_1"/>
<dbReference type="InParanoid" id="Q96CV9"/>
<dbReference type="KO" id="K19946"/>
<dbReference type="OMA" id="QGNIPEH"/>
<dbReference type="OrthoDB" id="745047at2759"/>
<dbReference type="PhylomeDB" id="Q96CV9"/>
<dbReference type="TreeFam" id="TF326608"/>
<dbReference type="PathwayCommons" id="Q96CV9"/>
<dbReference type="Reactome" id="R-HSA-2565942">
<property type="pathway name" value="Regulation of PLK1 Activity at G2/M Transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8854214">
<property type="pathway name" value="TBC/RABGAPs"/>
</dbReference>
<dbReference type="SIGNOR" id="Q96CV9"/>
<dbReference type="BioGRID-ORCS" id="10133">
<property type="hits" value="9 hits in 885 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="OPTN">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Optineurin"/>
<dbReference type="GenomeRNAi" id="10133"/>
<dbReference type="Pharos" id="Q96CV9">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q96CV9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="RNAct" id="Q96CV9">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000123240">
<property type="expression patterns" value="Expressed in amniotic fluid and 249 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q96CV9">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96CV9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005776">
<property type="term" value="C:autophagosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0055038">
<property type="term" value="C:recycling endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005802">
<property type="term" value="C:trans-Golgi network"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0070530">
<property type="term" value="F:K63-linked polyubiquitin modification-dependent protein binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031593">
<property type="term" value="F:polyubiquitin modification-dependent protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030674">
<property type="term" value="F:protein-macromolecule adaptor activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017137">
<property type="term" value="F:Rab GTPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008219">
<property type="term" value="P:cell death"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0034620">
<property type="term" value="P:cellular response to unfolded protein"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050829">
<property type="term" value="P:defense response to Gram-negative bacterium"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007030">
<property type="term" value="P:Golgi organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090161">
<property type="term" value="P:Golgi ribbon formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043001">
<property type="term" value="P:Golgi to plasma membrane protein transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001920">
<property type="term" value="P:negative regulation of receptor recycling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061734">
<property type="term" value="P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010508">
<property type="term" value="P:positive regulation of autophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1904417">
<property type="term" value="P:positive regulation of xenophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034067">
<property type="term" value="P:protein localization to Golgi apparatus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043122">
<property type="term" value="P:regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="IDEAL" id="IID00348"/>
<dbReference type="InterPro" id="IPR032419">
<property type="entry name" value="CC2-LZ_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR021063">
<property type="entry name" value="NEMO_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR034735">
<property type="entry name" value="NEMO_ZF"/>
</dbReference>
<dbReference type="InterPro" id="IPR032939">
<property type="entry name" value="Optineurin"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR31553:SF2">
<property type="entry name" value="PTHR31553:SF2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16516">
<property type="entry name" value="CC2-LZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF11577">
<property type="entry name" value="NEMO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51801">
<property type="entry name" value="ZF_CCHC_NOA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0036">Amyotrophic lateral sclerosis</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0955">Glaucoma</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Optineurin" id="PRO_0000058066">
<location>
<begin position="1"/>
<end position="577"/>
</location>
</feature>
<feature type="zinc finger region" description="CCHC NOA-type" evidence="9">
<location>
<begin position="547"/>
<end position="577"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with Rab8">
<location>
<begin position="58"/>
<end position="209"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HD">
<location>
<begin position="411"/>
<end position="577"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MYO6" evidence="24">
<location>
<begin position="412"/>
<end position="520"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="8">
<location>
<begin position="38"/>
<end position="170"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="8">
<location>
<begin position="239"/>
<end position="508"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR">
<location>
<begin position="176"/>
<end position="181"/>
</location>
</feature>
<feature type="short sequence motif" description="UBAN">
<location>
<begin position="474"/>
<end position="479"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1" evidence="6 7 29">
<location>
<position position="177"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="198"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="342"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="526"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_013261" evidence="43">
<location>
<begin position="1"/>
<end position="57"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_013262" evidence="42">
<location>
<begin position="210"/>
<end position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In GLC1E; dbSNP:rs200710076." id="VAR_021537" evidence="19 21 23">
<original>H</original>
<variation>D</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In GLC1E; selectively promotes cell death of retinal ganglion cells probably by inducing TBC1D17-mediated inhibition of autophagy; altered interaction with RAB8A; no effect on interaction with TBC1D17; increases interaction with TFRC and impairs its endocytic recycling; increases interactions with TBK1; decreases self-association; disturbs transition from the ER to Golgi; dbSNP:rs28939688." id="VAR_021538" evidence="13 25 26 30 32 36">
<original>E</original>
<variation>K</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; may modify intraocular pressure and increase risk of GLC1E and NPG; induces TFRC degradation leading to autophagic death in retinal ganglion cells; dbSNP:rs11258194." id="VAR_021539" evidence="13 18 22 23 31">
<original>M</original>
<variation>K</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In GLC1E; dbSNP:rs1346865805." id="VAR_021540" evidence="16">
<original>E</original>
<variation>D</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_021541" evidence="13 39 41">
<original>P</original>
<variation>S</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="Requires 2 nucleotide substitutions." id="VAR_021542" evidence="13 39 41">
<original>K</original>
<variation>H</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs750088207." id="VAR_021543" evidence="13 39 41">
<original>S</original>
<variation>R</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS12; no effect on Golgi subcellular location; no effect on protein expression level; increased Golgi fragmentation; decreased Golgi ribbon formation; increased susceptibility to endoplasmic reticulum (ER) stress; dbSNP:rs761558354." id="VAR_078108" evidence="37">
<original>V</original>
<variation>F</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7068431." id="VAR_030769">
<original>S</original>
<variation>P</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs523747." id="VAR_021544">
<original>E</original>
<variation>K</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_021545" evidence="13 39 41">
<original>T</original>
<variation>P</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS12; dbSNP:rs267606929." id="VAR_063597" evidence="28">
<original>E</original>
<variation>G</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="sequence variant" description="In GLC1E; juvenile onset; dbSNP:rs373425395." id="VAR_021546" evidence="16 20">
<original>H</original>
<variation>R</variation>
<location>
<position position="486"/>
</location>
</feature>
<feature type="sequence variant" description="In GLC1E; unknown pathological significance; dbSNP:rs75654767." id="VAR_021547" evidence="13 17 23">
<original>R</original>
<variation>Q</variation>
<location>
<position position="545"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces cell death, decreased interaction with TFRC; when associated with N-474." evidence="26 36">
<original>E</original>
<variation>K</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with MAP1LC3A and GABARAPL1, no effect on binding to linear ubiquitin." evidence="29 33">
<original>F</original>
<variation>A</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases interaction with MAP1LC3B." evidence="29 33">
<original>F</original>
<variation>W</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes colocalization with cytosolic Salmonella." evidence="29">
<original>DF</original>
<variation>NA</variation>
<location>
<begin position="474"/>
<end position="475"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces cell death, decreased interaction with TFRC; when associated with K-50." evidence="26 27 36">
<original>D</original>
<variation>N</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant reduction in ubiquitin binding and interaction with TBK1. Inhibits localization to recycling endosomes and disrupts interaction with TFRC. Loss of ability to inhibit the activation of the IFNB promoter in response to TLR3 or RIG-I signaling." evidence="26 27 36">
<original>D</original>
<variation>N</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAC26850." ref="8" evidence="44">
<original>A</original>
<variation>V</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="30"/>
<end position="33"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="37"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="178"/>
<end position="180"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="447"/>
<end position="497"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="556"/>
<end position="560"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="561"/>
<end position="564"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="566"/>
<end position="574"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LO4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LUE"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5AAZ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5B83"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EOF"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01142"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10756201"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10807909"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11137014"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11834836"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12379221"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12646749"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939304"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14597044"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14627677"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15226658"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15326130"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15370540"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15498064"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15557444"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15837803"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17389490"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20085643"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20174559"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20428114"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21617041"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22854040"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23357852"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23669351"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23805866"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23908376"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24705354"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24752605"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27534431"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27538435"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9488477"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9700202"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9488477"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000305"/>
<evidence key="45" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12379221"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12646749"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20085643"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22854040"/>
</source>
</evidence>
<sequence length="577" mass="65922" checksum="2BAF841BA515AAE2" modified="2018-03-28" version="3">MSHQPLSCLTEKEDSPSESTGNGPPHLAHPNLDTFTPEELLQQMKELLTENHQLKEAMKLNNQAMKGRFEELSAWTEKQKEERQFFEIQSKEAKERLMALSHENEKLKEELGKLKGKSERSSEDPTDDSRLPRAEAEQEKDQLRTQVVRLQAEKADLLGIVSELQLKLNSSGSSEDSFVEIRMAEGEAEGSVKEIKHSPGPTRTVSTGTALSKYRSRSADGAKNYFEHEELTVSQLLLCLREGNQKVERLEVALKEAKERVSDFEKKTSNRSEIETQTEGSTEKENDEEKGPETVGSEVEALNLQVTSLFKELQEAHTKLSEAELMKKRLQEKCQALERKNSAIPSELNEKQELVYTNKKLELQVESMLSEIKMEQAKTEDEKSKLTVLQMTHNKLLQEHNNALKTIEELTRKESEKVDRAVLKELSEKLELAEKALASKQLQMDEMKQTIAKQEEDLETMTILRAQMEVYCSDFHAERAAREKIHEEKEQLALQLAVLLKENDAFEDGGRQSLMEMQSRHGARTSDSDQQAYLVQRGAEDRDWRQQRNIPIHSCPKCGEVLPDIDTLQIHVMDCII</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

